Nonsteroidal anti-inflammatory drug use for over 2 years was associated with a lower risk for dementia, especially ...

AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate UpdateLandmark exclusive option and license deal with Takeda for ...

Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1.69 Bn in 2023, and is expected to exhibit a CAGR of 31.1% by 2030. Mr. Shah Coherent Market Insights Pvt. Ltd.

For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons ...

An appointment with Wendell Helveston, M.D., a neurologist in Hattiesburg, MS, led to a series of diagnostic tests, such as ...

A new international study has identified key genetic factors that may protect against Alzheimer’s disease (AD), offering ...

Scientists at Scripps Research developed a stable form of carnosic acid, which enhanced memory function and improved ...

Chicago area scientists have identified the genes that drive the process of Alzheimer’s disease and are working to make the drug Lecanemab even better by identifying which genes are active ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Reducing seven risk factors for heart disease and having higher Life's Simple 7 scores may help decrease biomarkers for ...

New research suggests enhancing the brain’s own immune cells could help clear plaques associated with Alzheimer’s disease.

Not the Same. In amyloid-negative people (left) few tangles accumulate over a decade. In amyloid-positives (right), tangles grow faster in women (orange) than men (blue). [Courtesy of Coughlan et al., ...